PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsPulmonary emphysema
MeSH D011656 - pulmonary emphysema
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D029424:Chronic obstructive pulmonary disease
$
Success rate
D011656: 
Pulmonary emphysema
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Alembic PharmaceuticalsArformoterol Arformoterol  2022-05-10   
AllerganAlbuterol, Ipratropium Albuterol Ipratropium  2007-12-31   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/1
Phase 3
90%
9/10
Approved: 9Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Arbor Pharmaceuticals
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use